JPWO2004018679A1 - 癌診断のための方法およびキット - Google Patents

癌診断のための方法およびキット Download PDF

Info

Publication number
JPWO2004018679A1
JPWO2004018679A1 JP2004530611A JP2004530611A JPWO2004018679A1 JP WO2004018679 A1 JPWO2004018679 A1 JP WO2004018679A1 JP 2004530611 A JP2004530611 A JP 2004530611A JP 2004530611 A JP2004530611 A JP 2004530611A JP WO2004018679 A1 JPWO2004018679 A1 JP WO2004018679A1
Authority
JP
Japan
Prior art keywords
cancer
polypeptide
factor
nucleic acid
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004530611A
Other languages
English (en)
Japanese (ja)
Inventor
英昭 島田
英昭 島田
毅 朝長
毅 朝長
一之 松下
一之 松下
武徳 落合
武徳 落合
文夫 野村
文夫 野村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, National Institute of Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Publication of JPWO2004018679A1 publication Critical patent/JPWO2004018679A1/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2004530611A 2002-08-23 2003-08-22 癌診断のための方法およびキット Pending JPWO2004018679A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002244249 2002-08-23
JP2002244249 2002-08-23
PCT/JP2003/010676 WO2004018679A1 (fr) 2002-08-23 2003-08-22 Methode et trousse de diagnostic du cancer

Publications (1)

Publication Number Publication Date
JPWO2004018679A1 true JPWO2004018679A1 (ja) 2006-01-19

Family

ID=31944122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004530611A Pending JPWO2004018679A1 (ja) 2002-08-23 2003-08-22 癌診断のための方法およびキット

Country Status (3)

Country Link
JP (1) JPWO2004018679A1 (fr)
AU (1) AU2003235316A1 (fr)
WO (2) WO2004018518A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784187B1 (ko) * 2003-04-21 2007-12-10 히데아키 시마다 세포자멸 유도제 및 세포자멸 유도방법
EP1845156A4 (fr) 2005-01-05 2008-04-23 Univ Chiba Nat Univ Corp Gène spécifique du cancer et kit de diagnostic utilisant ce dernier
JP4677566B2 (ja) * 2005-01-06 2011-04-27 国立大学法人 千葉大学 癌遺伝子及びそれを利用した診断キット
JP4806776B2 (ja) * 2006-01-27 2011-11-02 国立大学法人 千葉大学 ｃ−ｍｙｃ遺伝子転写抑制因子ＦＩＲのスプライシングバリアント又はイントロン２内の４塩基繰り返し配列による癌検出方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055350A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer chez l'homme
WO2001064835A2 (fr) * 2000-02-28 2001-09-07 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74839A (en) * 1993-10-22 1997-02-28 Univ Texas A novel nuclear mitotic phosphoprotein
AU1621400A (en) * 1998-11-12 2000-05-29 Board Of Trustees Of The Leland Stanford Junior University Novel phosphodiesterase interacting proteins
WO2001055309A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2402735A1 (fr) * 2000-03-13 2001-10-04 Incyte Genomics, Inc. Facteurs de transcription
AU2001275072A1 (en) * 2000-05-31 2001-12-11 The Scripps Research Institute Molecular marker for mitosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055350A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer chez l'homme
WO2001064835A2 (fr) * 2000-02-28 2001-09-07 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
JPN6009020487, Ｈｏｍｏ ｓａｐｉｅｎｓ ｐｏｌｙ−Ｕ ｂｉｎｄｉｎｇ ｓｐｌｉｃｉｎｇ ｆａｃｔｏｒ ６０ＫＤａ， ｍＲＮＡ （ｃＤＮＡ ｃｌｏｎｅ ＭＧＣ：９９５８ ＩＭＡＧＥ：３８７７５６３）， ｃｏｍｐｌｅｔ *
JPN6009020488, Ｈｏｍｏ ｓａｐｉｅｎｓ ＦＢＰ ｉｎｔｅｒａｃｔｉｎｇ ｒｅｐｒｅｓｓｏｒ （ＦＩＲ） ｍＲＮＡ， ｃｏｍｐｌｅｔｅ ｃｄｓ．，［ｏｎｌｉｎｅ］，ＧｅｎＢａｎｋ，２００１年１１ *
JPN6009020491, Ｍｏｌ．Ｃｅｌｌ，Ｖｏｌ．５，Ｎｏ．２（２０００）ｐ．３３１−３４１ *
JPN6009020493, ＲＮＡ，Ｖｏｌ．６，Ｎｏ．１（２０００）ｐ．６６−７８ *
JPN6009020497, ＲＮＡ，Ｖｏｌ．５，Ｎｏ．１２（１９９９）ｐ．１５４８−１５６０ *
JPN6009022226, Ｈｏｍｏ ｓａｐｉｅｎｓ ｐｏｌｙ−Ｕ ｂｉｎｄｉｎｇ ｓｐｌｉｃｉｎｇ ｆａｃｔｏｒ ６０ＫＤａ， ｍＲＮＡ （ｃＤＮＡ ｃｌｏｎｅ ＭＧＣ：９８３５ ＩＭＡＧＥ：３８６３６６０）， ｃｏｍｐｌｅｔ *
JPN6010013263, Ｃｅｌｌ，Ｖｏｌ．１０４，Ｎｏ．３（２００１）ｐ．３５３−３６３ *

Also Published As

Publication number Publication date
AU2003235316A1 (en) 2004-03-11
WO2004018679A1 (fr) 2004-03-04
WO2004018518A1 (fr) 2004-03-04

Similar Documents

Publication Publication Date Title
JP5589149B2 (ja) 癌に関与するポリヌクレオチド配列およびポリペプチド配列
KR101132579B1 (ko) 파골 세포 관련 단백질을 표적으로 한 항체
CA2539709A1 (fr) Nouvelles cibles therapeutiques pour le traitement du cancer
CA2516128A1 (fr) Nouvelles cibles therapeutiques pour le cancer
JP2006515318A (ja) 特異的に発現する癌関連遺伝子、それによってコードされるポリペプチドおよびその使用方法
JP2006500946A (ja) 精巣精上皮腫の診断方法
WO2004058146A2 (fr) Nouvelles compositions et nouveaux procedes de traitement du cancer
US20100144543A1 (en) Epigenetic silencing of tumor suppressor genes
JP2005537007A (ja) 結腸癌および胃癌の診断方法
US7348418B2 (en) Carcinoma-related genes and polypeptides and methods of use thereof
US20080182250A1 (en) Method for detecting multiple myeloma and method for inhibiting the same
NZ538982A (en) Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
EP1666600B1 (fr) Procédés pour augmenter l'efficacité de la thérapie du cancer
JPWO2004018679A1 (ja) 癌診断のための方法およびキット
AU2003299897B2 (en) Novel compositions and methods in cancer
US20200002774A1 (en) Breast cancer susceptibility gene gt198 and uses thereof
JP2008534017A (ja) 癌の診断および治療のためのｄｋｋｌ−１のスプライス産物の調節因子
WO2003055506A1 (fr) Medicaments pour la prevention et le traitement du cancer
US20120195916A1 (en) Method of treating cancer by inhibiting trim59 expression or activity
US6746867B1 (en) Mammalian mesoderm induction early response (MIER) gene family
KR20030031998A (ko) 암 치료의 효능을 증진시키는 방법
JP2004514445A (ja) 新規な網膜特異的ヒトタンパク質Ｃ７ｏｒｆ９、Ｃ１２ｏｒｆ７、ＭＰＰ４およびＦ３７９
US20040241760A1 (en) Kinesin-like proteins and methods of use
JPWO2003046182A1 (ja) 精巣由来のヒトグリオーマ抗原
CA2516138A1 (fr) Nouveaux cibles therapeutiques du recepteur de couplage a la proteine g dans le cancer

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060822

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060822

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090512

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100316

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100514

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100608